Abstract
We report a case of Vogt–Koyanagi–Harada (VKH) disease in a 30-year-old patient who was receiving interferon-alpha and ribavirin therapy for chronic hepatitis C virus infection. The intraocular inflammation responded to systemic corticosteroid and mycophenolate mofetil treatment. Physicians should be aware of the association between interferon-alpha and ribavirin therapy for hepatitis C virus infection and the development of VKH disease.
References
Moorthy RS, Inomata H, Rao NA (1995) Vogt–Koyanagi–Harada syndrome. Surv Ophthalmol 39:265–292
Yamaki K, Kondo I, Nakamura H et al (2000) Ocular and extraocular inflammation induced by immunization of tyrosinase related protein 1 and 2 in Lewis Rats. Exp Eye Res 71:361–369
Kawano T, Shigehira M, Uto H et al (1996) Retinal complications during interferon therapy for chronic hepatitis C. Am J Gastroenterol 91:309–313
Kasahara A, Hiraide A, Tomita N et al (2004) Vogt–Koyanagi–Harada disease occurring during interferon alpha therapy for chronic hepatitis C. J Gastroenterol 39:1106–1109
Sène D, Touitou V, Bodaghi B et al (2007) Intraocular complications of IFN-alpha and ribavirin therapy in patients with chronic viral hepatitis C. World J Gastroenterol 13:3137–3140
Sylvestre DL, Disston AR, Bui DP (2003) Vogt–Koyanagi–Harada disease associated with interferon alpha-2b/ribavirin combination therapy. J Viral Hepat 10:467–470
Papastathopoulos K, Bouzas E, Naoum G et al (2006) Vogt–Koyanagi–Harada disease associated with interferon-A and ribavirin therapy for chronic hepatitis C infection. J Infect 52:e59–e61
Touitou V, Bodaghi B, Cassoux N et al (2005) Vogt–Koyanagi–Harada disease in patients with chronic hepatitis C. Am J Ophthalmol 140:949–952
Touitou V, Sene D, Fardeau C et al (2007) Interferon-alpha2a and Vogt–Koyanagi–Harada disease: a double-edged sword? Int Ophthalmol 27:211–215
Pellicano R, Smedile A, Peyre S et al (2005) Autoimmune manifestations during interferon therapy in patients with chronic hepatitis C: the hepatologist’s view. Minerva Gastroenterol Dietol 51:55–61
Acknowledgements
The authors thank Ms. Connie B. Unisa-Marfil for secretarial work. This work was supported by Medical Research Chair funded by Dr. Nasser Al-Rasheed.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Al-Muammar, A.M., Al-Mudhaiyan, T.M., Al Otaibi, M. et al. Vogt–Koyanagi–Harada disease occurring during interferon-alpha and ribavirin therapy for chronic hepatitis C virus infection. Int Ophthalmol 30, 611–613 (2010). https://doi.org/10.1007/s10792-010-9357-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-010-9357-0